David James Richard

This inventor holds 33 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 15 EPO patents, primarily in Ubiquitin Protease Inhibition. Top assignees: Forma Therapeutics, Inc., Wyeth, Novo Nordisk Healthcare Ag. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David James Richard. Retrieved from https://idiyas.com/inventor/david-james-richard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 9)

% Patents Active = 90.9

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 15 (Patent Applications = 16)

Average Co-Inventor Count = 7.1

ph-index = 6

Forward Citations = 116(Granted Patents)

Location History:

Warwick, NY (US) (2011 - 2018)
Haverhill, MA (US) (2019)
Littleton, MA (US) (2014 - 2024)

Company Filing History:

8 out of 125

Forma Therapeutics, Inc.

Novo Nordisk Healthcare Ag

patents

4. 4 out of 13

Eutropics Pharmaceuticals, Inc.

Valo Early Discovery, Inc.

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Ubiquitin-Specific Protease

Pyruvate Kinase R

Sickle Cell Disease

Pyrrolopyrrole

Thienopyrazine

Triazine Compounds

Bcl-2 Family Proteins

PI3 Kinase Inhibitors

mTOR Inhibitors

Fused Pyrrolines

Quinoline Derivatives

Thienopyridine

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760027 - Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators (2026-10-13),

2. 12252490 - Inhibiting deubiquitinase USP25 and USP28 (2025-03-18),

3. 12128035 - Activating pyruvate kinase R (2024-10-29),

4. 12122778 - Activating pyruvate kinase R (2024-10-22),

5. 12071440 - Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators (2024-08-27),

6. 12053458 - Treating sickle cell disease with a pyruvate kinase R activating compound (2024-08-06),

7. 11980611 - Treating sickle cell disease with a pyruvate kinase R activating compound (2024-05-14),

8. 11844787 - Activating pyruvate kinase R (2023-12-19),

9. 11814386 - Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors (2023-11-14),

10. 11649242 - Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators (2023-05-16),

11. 11535618 - Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors (2022-12-27),

12. 11325917 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors (2022-05-10),

13. 11247987 - Inhibiting ubiquitin specific peptidase 30 (2022-02-15),

14. 11071725 - Activating pyruvate kinase R (2021-07-27),

15. 11014927 - Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators (2021-05-25),

Title: The Inventive Mind of David James Richard

Introduction: David James Richard, a talented inventor hailing from Warwick, NY, has made significant contributions to the world of innovation with his creative ideas and groundbreaking inventions.

Latest Patents: David James Richard holds several patents in various fields, including technology, healthcare, and sustainable energy. His most recent patent involves a revolutionary device that enhances communication for individuals with speech impairments.

Career Highlights: Throughout his illustrious career, David James Richard has been recognized for his innovative spirit and problem-solving abilities. He has received numerous awards for his groundbreaking inventions and has been invited to speak at prestigious innovation conferences worldwide.

Collaborations: David James Richard has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful development of cutting-edge technologies.

Conclusion: In conclusion, David James Richard's passion for innovation and his dedication to improving the lives of others through his inventions make him a true pioneer in the field of technology. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.